Wow, this is really really great. TONS OF DISTRIBUTORS. Now can you please point me to one store outside the state of NC that actually carries the product? Thanks.

UPDATED Share structure as of today per Holladay Stock Transfer

OS: 1,712,968,871
AS: 1.75 Billion

That is an increase in the OS of 47,650,000 since the last confirmed number.

Color, I think your sarcasm detector has shorted out.

I've heard you argue this point on other boards and it's simply a silly position. Many companies package the same product differently for different markets with slight variations. There is nothing dishonest about it. While a few of the points you make in your posts are valid, this isn't one of them.

I don't believe there are any fines or penalties associated with filing excessive NT-10Qs. As long as the filer complies with the extended deadline to file their 10Q or 10K, then they're fine. Also, the 5 day timeline is correct this time, as an NT-10Q gives you a 5 day extension on quarterly filings, and a 15 day extension on annual filings. What he did wrong previously was leave the 5 day language on his NT-10K, instead of changing it to 15.

Somebody looking to dump $1+ million shares at $.0074.

You've got books. They're just fake.

Looks like YESD was too busy marketing a product that's not on the market to bother getting their financials filed on time.

It would not surprise me at all if they receive clearance to market the device for additional post-surgical recovery uses. Afterall it is basically the same purpose for which it is already approved, just a different part of the body. The big question is if this will help them along their way towards gaining OTC clearance for Actipatch/Allay. The company says it will, but I have a hard time seeing the correlation. Only time will tell.

I agree. Nice rebound from the lows and then dropped on low volume at the end. Hard to say what it will do tomorrow.

As I stated, I will remove posts that I believe to be in violation of the TOS. If you believe that a post violates the TOS and has not been removed, then please click the link and report it to the Admins. Now, please get back to the topic of BIEL. Thanks.

Posts about the company's history are on-topic and are not in violation of the TOS. As such, I have no reason to remove them unless they fall under the SPAM category. Again, if you feel that a post is in violation of the TOS and I have not removed it then please utilize the reporting function so that an Admin can review. As a note, I will be removing both your original post, and this response as they are off-topic.

I have been added as the board moderator and as such my primary role is to ensure that posts adhere to the IHUB Terms of Service. If you are unclear as to what types of posts violate the TOS then please refer to the stickied links provided by the Admin. Also, if you feel that a post violates the TOS and has not been removed, then you can click the "Report TOS Violation" link at the bottom right of the post and the admins will review for removal.

I have a limited amount of time available to manage this board, so if anybody would be interested in being added as an assistant mod and has a clear understanding of the TOS, then please let me know.

Thanks, and let's keep the conversation on-topic.

No argument regarding the pipeline, however their failure to deliver on past agreements means that counting those revenues before they are recognized is sketchy at best.

There is a better chance of the U.S. recovering its AAA rating before market open today then CSKH showing $4 million in revenue for June on their Q2 financial statements IMO. Again, they have contracts in the pipeline, but they won't get paid on them until they're complete.

And, if you subtract out the $132,000 they raised by selling shares, which the CEO records as revenue, then you end up with Gross Profit of $9,000, and a Net Loss of over $270,000.

IMO, it would be irresponsible of the board mod to sticky a PR that has been proven to be false.

Except that there is no relationship between the two. YESD put out a vague statement that an unnamed oil company might be interested if studies show it works. If there was anything real there, then they would have dropped the name.

The SEC is going to love this PR based on incorrect financial statements.

You also have to account for the fact that the CEO counts shares of stock as revenue on the income statement, which is a big NO-NO. There is no question that this company is losing money from operations and supporting itself (mostly it's management) with share sales.

It sounds like all of their other customers have jumped ship due to lackluster marketing results. Motorbooster is all they have left so they're throwing up the white flag.

I see you're back in for a flip Diddi.

Oh, these make perfect sense. Let's see...

The shareholders equity section is a total mess, as usual.

Apparently Cost of Sales is a revenue stream, as according to the income statement you add them to Gross Income to come up with Gross Margin. LOL. I guaranty his Gross Income number includes the $300+ raised through dilution during the quarter.

Also according to these the OS was over 346 million as of June 30. It's late, so my memory may be fuzzy, but wasn't the filing to increase the AS to 500 million done AFTER that date? So, at some point he had more shares outstanding than were authorized? Suprise, surprise.

He really didn't even bother trying to pretend to know what a statement of cash flows was this time.

Yes, I'm sure these were prepared by somebody with years and years of accounting experience. Somebody who should never be allowed to touch a calculator again.

For investor's sake I hope you're right. Almost time for them to prove it.

GASP!!! You mean PRs about DTC Chills, Youtube hits, office space rental, and media mentions aren't driving the PPS through the roof??????? But...but...but

Yeah, you can't really count anything until you see the filings. They've announced millions of dollars in signed contracts, but they did that last year too and only a fraction of those contracts were completed. It will also depend on what the change to primarily residential installations does to their operating margin, because they have been slim in the past, and if they get any smaller than it will be very difficult for CSKH to ever dig their way out of this hole.

Cross your fingers that most of those announced contracts actually come to fruition.

Yeah, that's not right either. They are trading at 1X last year's REVENUE. Earnings = net income and CSKH was almost $10 million in the red last year. 1X revenue is a fairly common valuation for companies losing money.

New management? Real revenue? Both?

Just when I think I've read the dumbest PR ever...BW goes and tops himself. Props to you BW!!!!

Color, when you spoke with him did you inquire as to which major Canadian retailers were carrying the product as you reported in early February?

Again, this is not the FDA news that investors have been awaiting since 2009. This is simply for an additional prescription indication for treating injuries after surgery. It has already been approved for the same purpose following eye surgery.

Also, share structure is completely different today compared to what it was when it ran to 12. This shouldn't really need to be pointed out, but the current OS is going to severely limit any runs as well.

Really? Because BIEL already has a device approved for presciption use. This is more of the same.

Look, this is great news for BIEL, but it is not OTC clearance, and it does not guaranty OTC clearance either. Don't get ahead of yourself, but enjoy the ride while it's here.

LOL. Back when the site was still working I personally viewed the Walmart Canada logo listed as one of the places it was available for sale. If you had been around back then you would have as well. However, if you go back and read where I mentioned Walmart I said:

Unfortunately, the site that listed it as being available in Walmart Canada is no longer functioning. It was:

www.ActiPatchPainTherapy.com

If you do a Google search for Actipatch Walmart Canada, you'll find several discussions from 2009 about this topic.

I agree, but trusting a pinksheet CEO who's proven to be unreliable is not DD, IMO.

I prefer to base my DD on verifiable facts, as in the information contained in the company's financial statements. You have been talking to the CEO for a long time and very little of what he has told you has come to fruition. Andrew Whelan has a documented history of saying one thing and doing another, so any information obtained directly from him is not reliable IMO.

My opinions are just as well supported as those of you who believe this product is going to fly off the shelves after FDA approval. Moreso even, because in the real world it takes time and money to get your product into the public consciousness and gain market share. I get it, you disagree with my opinion. Good for you. Now how about you focus on the company and stop worrying about attacking me personally?

As has been posted many times by people with knowledge of the company, the products have been available for OTC sales in Canada for over 5 years. They even made it onto the shelves in Walmart Canada for a while I believe and yet neither the companies sales numbers, nor the stock price went through the roof. Why? Because bringing a product to market is not a simple process.